Works matching IS 00178748 AND DT 2021 AND VI 61 AND IP 9
Results: 20
Issue Information.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1, doi. 10.1111/head.14235
- Publication type:
- Article
The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1403, doi. 10.1111/head.14225
- By:
- Publication type:
- Article
Enlarging the spectrum of cluster headache: Extracranial autonomic involvement revealed by voice analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1452, doi. 10.1111/head.14222
- By:
- Publication type:
- Article
Did she have an epidural? The long‐term consequences of postdural puncture headache and the role of unintended dural puncture.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1314, doi. 10.1111/head.14221
- By:
- Publication type:
- Article
Subjective sensory sensitivity and its relationship with anxiety in people with probable migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1342, doi. 10.1111/head.14219
- By:
- Publication type:
- Article
The Headache in Emergency Departments study: Opioid prescribing in patients presenting with headache. A multicenter, cross‐sectional, observational study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1387, doi. 10.1111/head.14217
- By:
- Publication type:
- Article
The road taken.
- Published in:
- 2021
- Publication type:
- Editorial
What's in a name: What a difference a day (or two) makes.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1460, doi. 10.1111/head.14215
- By:
- Publication type:
- Article
Intravenous ibuprofen for acute treatment of migraine: A double‐blind, randomized, placebo‐controlled pilot study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1432, doi. 10.1111/head.14214
- By:
- Publication type:
- Article
Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1306, doi. 10.1111/head.14213
- By:
- Publication type:
- Article
Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1441, doi. 10.1111/head.14212
- By:
- Publication type:
- Article
Advancing our commitment to our peer reviewers.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1299, doi. 10.1111/head.14211
- By:
- Publication type:
- Article
Persistent posttraumatic headaches and functioning in veterans: Injury type can matter.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1334, doi. 10.1111/head.14210
- By:
- Publication type:
- Article
Virtual issue: Diversity, equity, and inclusion.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1302, doi. 10.1111/head.14209
- By:
- Publication type:
- Article
Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1411, doi. 10.1111/head.14208
- By:
- Publication type:
- Article
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1421, doi. 10.1111/head.14206
- By:
- Publication type:
- Article
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1376, doi. 10.1111/head.14196
- By:
- Publication type:
- Article
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1351, doi. 10.1111/head.14194
- By:
- Publication type:
- Article
Narrative review of neuroimaging in migraine with aura.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1324, doi. 10.1111/head.14191
- By:
- Publication type:
- Article
Headache infusion centers: A survey on treatments provided, infusion center operations, and barriers to developing new infusion centers.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1364, doi. 10.1111/head.14172
- By:
- Publication type:
- Article